A novel molecule, designated 2H7, demonstrates significant cross-reactivity against both CD20 targets found in monkey and person species. Its discovery holds potential for future studies into lymphoma approaches, https://www.targetmol.com/compound/anti-monkey-human-cd20-antibody-2h7